May 11 (Reuters)-
Takara Bio Inc.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2023 Mar 31, 2022 Mar 31, 2024 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 78.14 67.70 53.30 22.80
(+15.4 pct) (+46.9 pct) (-31.8 pct) (-30.0 pct)
Operating 20.54 28.90 8.00 2.10
(-28.9 pct) (+107.1 pct) (-61.1 pct) (-80.7 pct)
Recurring 20.68 28.46 8.20 2.10
(-27.3 pct) (+101.0 pct) (-60.4 pct) (-80.8 pct)
Net
Net 16.01 19.85 5.50 1.20
(-19.3 pct) (+107.9 pct) (-65.7 pct) (-85.9 pct)
EPS 132.97 yen 164.84 yen 45.67 yen 9.96 yen
Ann Div 42.00 yen 33.00 yen 17.00 yen
-Q2 Div NIL NIL NIL
-Q4 Div 42.00 yen 33.00 yen 17.00 yen
NOTE - Takara Bio Inc..
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4974.T